“ Evaluating the Antitumor Activity of Nintedanib by Solid Lipid Nanoparticle Drug Delivery System: In vitro and In vivo” (2026) Asian Journal of Pharmaceutics (AJP), 19(04). doi:10.22377/ajp.v19i04.7190.